The objective of this study was to assess the serological response against one of the valences included in the vaccine for the neonatal diarrhoea, the Labile Toxin (LT) produced by the ETEC. First of all, the IgG seroprofile was assessed using an ELISA against the LT antigen. Afterwards, to obtain the biological significance of these antibodies, the seroneutralization properties against the LT of swine sera were analyzed.
Neutralization of Escherichia coli labile toxin (LT)
Publications
Swine
Appeared in
IOVS Congress, 2012
The results clearly demonstrate that SUISENG® induce the production of specific antibodies against the LT toxin of Escherichia coli. The neutralization assay demonstrates that the antibodies elicited by the immunization are biologically active and they are able to neutralize completely the native toxin. The diarrhoea due to the infection with ETEC can be prevented by means of the neutralization of the main toxin (LT) responsible of the clinical signs. The immunization with SUISENG® induces the significant production neutralizing antibodies against this toxin.
Download this article
Related products
The first intradermal needle-free vaccine against Mycoplasma hyopneumoniae and PCV2, all in one, in suspension for injection
Live vaccine against porcine reproductive and respiratory syndrome (PRRS), in injectable freeze-dried tablet
Purified recombinant verotoxin 2e against edema disease, in suspension for injection
Inactivated vaccine, against progressive and non progressive swine atrophic rhinitis, in injectable suspension.
Inactivated vaccine against neonatal colibacillosis and Clostridium infections in swine, in injectable suspension
Inactivated vaccine against Clostridioides difficile and Clostridium perfringens type A infections in swine, in injectable suspension.
Inactivated vaccine against porcine parvovirus and swine erysipelas, in injectable suspension
Inactivated vaccine against swine erysipelas, parvovirosis and leptospirosis, in injectable suspension
Live vaccine against Aujeszky’s disease gE negative strain, in injectable freeze-dried tablet
Inactivated vaccine against swine erysipelas, in injectable suspension
Inactivated porcine against porcine parvovirus, in injectable suspension
Inactivated vaccine against enzootic pneumonia, in injectable suspension
Related services
Smart Vaccination by HIPRA is a revolutionary concept that combines: A smart vaccine including RFID technology in its label, a vaccination device which ensures precision and efficiency, and a new world of digital solutions in HIPRAlink Vaccination. All these elements are developed internally by HIPRA.
In Swine, the HIPRA SMART VACCINATION is spearheaded by our innovative MHYOSPHERE® PCV ID and UNISTRAIN® PRRS vaccines, the needle-free intradermal device Hipradermic® and the professional veterinary app HIPRAlink® Vaccination.
An innovative service based on data analysis that facilitates decision-making in swine
HIPRA Stats is a data analysis service for animal production companies.
Hipradermic® is an advanced needle-free injection device with wireless connectivity for the intradermal vaccination of pigs.
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
Access an advanced diagnostic service with maximum comfort and reliability
